HUMAN CD5+ (B1) B-CELLS IN HEALTH AND DISEASE

被引:0
|
作者
LYDYARD, PM [1 ]
YOUINOU, PY [1 ]
机构
[1] BREST UNIV HOSP, SCH MED, IMMUNOL LAB, BREST, FRANCE
来源
FUNDAMENTAL AND CLINICAL IMMUNOLOGY | 1994年 / 2卷 / 01期
关键词
CD5; B-CELLS; B1-CELLS; NATURAL ANTIBODIES; CLL; AUTOIMMUNE DISEASES;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD5 B cells (B1 cells) are the first B cells to be produced during ontogeny and usually utilise minimally mutated germ-line genes. They are mainly of the IgM class but may also express IgG and IgA. They produce low avidity auto and polyreactive antibodies (natural antibodies). There is evidence for and against B1 cells being a separate lineage. B1 cells probably play a role in setting up the idiotype network, antigen presentation and tolerance induction. Their relative importance of each of these different functions in maintaining an effective normal immune system is unclear. Chronic lymphocytic leukemia is a malignancy of the B1 population and Rheumatoid Arthritis probabLy represents an abnormal antigen-driven maturation of specific self-reactive anti-IgGFc clones. Since B1 cells are regulated by cytokines, other autoimmune diseases including some organ specific diseases where there is an increase in CD5 B cells, may represent abnormal cytokine regulation.
引用
收藏
页码:9 / 25
页数:17
相关论文
共 50 条
  • [21] CD5+ B-CELLS AT THE ONSET OF TYPE-1 DIABETES AND IN THE PREDIABETIC PERIOD
    SMERDON, RA
    PEAKMAN, M
    HUSSAIN, MJ
    WONG, FS
    WATKINS, PJ
    LESLIE, RDG
    VERGANI, D
    DIABETES CARE, 1994, 17 (07) : 657 - 664
  • [22] INCREASED CD5+ B-CELLS IN PATIENTS WITH INFECTIOUS-MONONUCLEOSIS
    HASSAN, J
    FEIGHERY, C
    BRESNIHAN, B
    WHELAN, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (03) : 375 - 376
  • [23] CD5+ B-CELLS IN MYASTHENIA-GRAVIS CLINICAL CORRELATIONS
    RAGHEB, S
    LISAK, RP
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 651 : 586 - 587
  • [24] CD5+ B-CELLS IN THE THYMUS OF PATIENTS WITH MYASTHENIA-GRAVIS
    TSUCHIDA, M
    HASHIMOTO, S
    ABO, T
    MIYAMURA, H
    HIRONO, T
    EGUCHI, S
    BIOMEDICAL RESEARCH-TOKYO, 1993, 14 (01): : 19 - 25
  • [25] CD5+ B-CELLS ARE DECREASED IN PERIPHERAL-BLOOD OF PATIENTS WITH CROHNS-DISEASE
    NEIL, GA
    SUMMERS, RW
    CHEYNE, BA
    CAPENTER, C
    HUANG, WL
    KANSAS, GS
    WALDSCHMIDT, TJ
    DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (09) : 1390 - 1395
  • [26] ANTI CD5 SUSTAINS THE PROLIFERATIVE RESPONSE OF IGM-ACTIVATED HUMAN CD5+ B-CELLS
    JAMIN, C
    DUEYMES, M
    LYDYARD, PM
    YOUINOU, P
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 42 (02) : 282 - 285
  • [27] VARIABLE GENE USAGE, PHYSIOLOGY AND DEVELOPMENT OF LY-1+ (CD5+) B-CELLS
    HARDY, RR
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (02) : 181 - 185
  • [28] Analysis of the immunoglobulin repertoire of human B-1 (CD5+) B cells.
    Brezinschek, HP
    Brezinschek, RI
    Foster, SJ
    Dorner, T
    Lipsky, PE
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 102 - 102
  • [29] INDUCTION OF ISOTYPE SWITCHING AND IG PRODUCTION BY CD5+ AND CD10+ HUMAN FETAL B-CELLS
    PUNNONEN, J
    AVERSA, GG
    VANDEKERCKHOVE, B
    RONCAROLO, MG
    DEVRIES, JE
    JOURNAL OF IMMUNOLOGY, 1992, 148 (11): : 3398 - 3404
  • [30] ARE BACTERIAL-ENDOTOXINS INVOLVED IN AUTOIMMUNITY BY CD5+ (LY-1+) B-CELLS
    VANROOIJEN, N
    IMMUNOLOGY TODAY, 1989, 10 (10): : 334 - 336